Developmental strategy for swellable/erodible matrix tablet of mirabegron: quality by design approach with various geometric properties and pharmacokinetic evaluation
first_published_at:Nov. 21, 2023, midnight / date_published:Nov. 21, 2023
Papers
-
21/11/2023 -
by
Ji Yeon Kim,
Tae Hwan Kim,
Eunbin Kim,
Du Hyung Choi
Objective:
This study aimed to devise a developmental strategy for matrix tablets containing mirabegron, incorporating a quality by design approach that considers geometric properties such as gel strength, erosion rate, …
